Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otovowen vs placebo for prevention of recurrent acute otitis media in young children
2012-000341-13Phase 3Completed
- Sponsor
- Weber & Weber
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute otitis media (AOM) and upper respiratory infection (URI) comparing Otovowen with Placebo (2 arms). Primary endpoint: Number of acute otitis media episodes per patient within 6 months. Started Apr 2012; status: completed.
02
Drugs
Otovowen
03
Conditions
acute otitis media (AOM)upper respiratory infection (URI)
Beyond the preview
Go deeper on 2012-000341-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000341-13.